Pharmacoeconomic analysis of anti-angiogenic therapy for diabetic macular edema
Te purpose of the study is to assess the economic consequences of the use of various anti-VEGF drugs in patients with diabetic macular edema (DME).Materials and methods. Te cost-effectiveness analysis and budget impact analysis was conducted from the payer perspective (health insurance system).Result...
Saved in:
Main Authors: | S. V. Nedogoda (Author), I. N. Barykina (Author), A. S. Salasyuk (Author), V. O. Smirnova (Author), E. A. Popova (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria
by: S. V. Nedogoda, et al.
Published: (2019) -
Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020) -
Pharmacoeconomic analysis of dapagliflozin in patients with chronic kidney disease and type 2 diabetes in the Russian Federation
by: Sergey V. Nedogoda, et al.
Published: (2024) -
Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018) -
Pharmacoeconomic analysis of dexamethasone intravitreal implant for the treatment of diabetic macular edema in Russia
by: A. S. Kolbin, et al.
Published: (2018)